HM
HealthCor Management Portfolio holdings
AUM
$109M
1-Year Return
11.46%
This Quarter Return
+13.7%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$2.37B
AUM Growth
-$351M
(-13%)
Cap. Flow
-$536M
Cap. Flow
% of AUM
-22.65%
Top 10 Holdings %
Top 10 Hldgs %
50.33%
Holding
61
New
23
Increased
10
Reduced
11
Closed
14
Top Buys
| 1 |
Zimmer Biomet
ZBH
|
$105M |
| 2 |
AGN
Allergan plc
AGN
|
$90.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
$65.9M |
| 4 |
Icon
ICLR
|
$55.8M |
| 5 |
UnitedHealth
UNH
|
$54.2M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$165M |
| 2 |
CVS Health
CVS
|
$153M |
| 3 |
Intuitive Surgical
ISRG
|
$144M |
| 4 |
LivaNova
LIVN
|
$139M |
| 5 |
CELG
Celgene Corp
CELG
|
$125M |
Sector Composition
| 1 | Healthcare | 91.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
CVS Health
CVS
$93.5B
| – | – |
-2,328,560
| Closed | -$153M |
|
52
Dynavax Technologies
DVAX
$1.19B
| – | – |
-4,613,280
| Closed | -$42.2M |
|
53
Encompass Health
EHC
$12.5B
| – | – |
-1,390,141
| Closed | -$68.2M |
|
54
Ionis Pharmaceuticals
IONS
$9.48B
| – | – |
0
| – | – |
|
|
55
LivaNova
LIVN
$3.15B
| – | – |
-1,517,780
| Closed | -$139M |
|
|
56
Regeneron Pharmaceuticals
REGN
$60.2B
| – | – |
-440,968
| Closed | -$165M |
|
57
SPDR S&P 500 ETF Trust
SPY
$659B
| – | – |
0
| – | – |
|
58
Stryker
SYK
$151B
| – | – |
-593,623
| Closed | -$93.1M |
|
|
ZSAN
59
DELISTED
Zosano Pharma Corporation
ZSAN
| – | – |
-16,309
| Closed | -$1.21M |
|
|
WCG
60
DELISTED
Wellcare Health Plans, Inc.
WCG
| – | – |
-462,370
| Closed | -$109M |
|
|
CELG
61
DELISTED
Celgene Corp
CELG
| – | – |
-1,947,640
| Closed | -$125M |
|